ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2017

Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway.

Esther Civantos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.